Home / Pharmaceuticals / Drug Delivery Technologies Market By Application (Oral, Pulmonary, Transdermal, Injectable, Nasal, Implantable & Others) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

Drug Delivery Technologies Market By Application (Oral, Pulmonary, Transdermal, Injectable, Nasal, Implantable & Others) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

Published: Apr 2016 | Report Code: 57779-04-16

Various drug delivery technologies assist in adjusting dosage release with best possible safety and efficacy. Drug delivery technologies simplify the challenge of patient compliance, facilitate precision in dosage and reduce side effects. For the purpose of this study, the global drug delivery devices market is studied in terms of mode of administration and geography.

In terms of mode of administration, the global drug delivery devices market is categorized into oral, pulmonary, injectable, nasal, implantable, and ocular, buccal etc. segments. Each of these segments is studied for their current market status and future prospect. Market size and forecast (in terms of USD Bn) for the period 2014 to 2022, with compounded annual growth rate (CAGR %) for 2016 to 2022.

Geographically, North America, Europe, Asia-Pacific, Latin America and Middle East and Africa together form the global drug delivery technologies market. Similar to segmentation by mode of administration the geographic markets are also studied in terms of their current and future market value. Market revenue and forecast for the period 2014 to 2022 along with the respective CAGRs for 2016 to 2022 are provided in this report for each respective regional market and certain key national markets. For further elucidation, the regional market segmentation is represented as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • Middle East and North Africa
    • Latin America

 Drug Delivery Technologies Market

Apart from market size and forecast this report on global drug delivery market, this report also includes qualitative information sets such as market dynamics information: drivers, challenges, and future prospects. Fractal map analysis for analyzing the overall market competition and attractive investment proposition tools are also included in the study. This report concludes with company profiles section that highlights key information of the major market players operating in the global drug delivery technologies market.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Drug Delivery Technologies Market, 2014-2022 (USD Bn)
2.2 Drug Delivery Technologies Market Share, by Mode of Administration, 2015 & 2022 (Value %)
2.3 Drug Delivery Technologies Market Share, by Geography, 2015 (Value %)

Chapter 3 Global Drug Delivery Technologies Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Fractal Map Analysis: by Key Market Players
3.6 Attractive Investment Proposition

Chapter 4 Global Drug Delivery Technologies Market Analysis, by Mode of Administration
4.1 Preface
4.2 Oral
4.3 Pulmonary
4.3.1 Pulmonary Drug Delivery Technology Market, 2014 – 2022 (USD Bn)
4.4 Transdermal
4.4.1 Transdermal Drug Delivery Technology Market, 2014-2022 (USD Bn)
4.5 Injectable
4.5.1 Injectable Drug Delivery Technology Market, 2014-2022 (USD Bn)
4.6 Nasal
4.6.1 Nasal Drug Delivery Technology Market, 2014-2022 (USD Bn)
4.7 Implantable
4.7.1 Implantable Drug Delivery Technology Market, 2014-2022 (USD Bn)
4.8 Others (Ocular, Buccal, Etc.)
4.8.1 Other Drug Delivery Technologies Market, 2014-2022 (USD Bn)

Chapter 5 Drug Delivery Technologies Market, by Geography
5.1 Preface
5.2 North America
5.2.1 North America Drug Delivery Technologies Market, by Country, 2014 – 2022 (USD Bn)
5.2.2 U.S. Drug Delivery Technologies Market, 2014-2022 (USD Bn)
5.2.3 Canada Drug Delivery Technologies Market, 2014-2022 (USD Bn)
5.3 Europe
5.3.1 Europe Drug Delivery Technologies Market, by Country, 2014 – 2022 (USD Bn)
5.3.2 U.K. Drug Delivery Technologies Market, 2014-2022 (USD Bn)
5.3.3 Germany Drug Delivery Technologies Market, 2014-2022 (USD Bn)
5.3.4 Rest of Europe Drug Delivery Technologies Market, 2014-2022 (USD Bn)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Drug Delivery Technologies Market, by Country, 2014 – 2022 (USD Bn)
5.4.2 Japan Drug Delivery Technologies Market, 2014-2022 (USD Bn)
5.4.3 China Drug Delivery Technologies Market, 2014-2022 (USD Bn)
5.4.4 Rest of Asia-Pacific Drug Delivery Technologies Market, 2014-2022 (USD Bn)
5.5 Middle East and Africa (MEA)
5.5.1 Middle East and Africa Drug Delivery Technologies Market, 2014 – 2022 (USD Bn)
5.6 Latin Ameirca
5.6.1 Latin America Drug Delivery Technologies Market, 2014-2022 (USD Bn)

Chapter 6 Company Profiles
6.1 Bayer AG
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
6.1.3 Product Positions/Portfolio
6.1.4 News Coverage
6.2 Becton, Dickinson and Company
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Positions/Portfolio
6.2.4 News Coverage
6.3 3M Company
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Positions/Portfolio
6.3.4 News Coverage
6.4 Antares Pharma, Inc.
6.4.1 Business Description
6.4.2 Financial Health and Budget Allocation
6.4.3 Product Positions/Portfolio
6.4.4 News Coverage
6.5 Johnson & Johnson
6.5.1 Business Description
6.5.2 Financial Health and Budget Allocation
6.5.3 Product Positions/Portfolio
6.5.4 News Coverage
6.6 Novartis AG
6.6.1 Business Description
6.6.2 Financial Health and Budget Allocation
6.6.3 Product Positions/Portfolio
6.6.4 News Coverage
6.7 Pfizer, Inc.
6.7.1 Business Description
6.7.2 Financial Health and Budget Allocation
6.7.3 Product Positions/Portfolio
6.7.4 News Coverage
6.8 F. Hoffmann La-Roche
6.8.1 Business Description
6.8.2 Financial Health and Budget Allocation
6.8.3 Product Positions/Portfolio
6.8.4 News Coverage
6.9 Sanofi
6.9.1 Business Description
6.9.2 Financial Health and Budget Allocation
6.9.3 Product Positions/Portfolio
6.9.4 News Coverage
6.10 Other Notable Players

List of Figures

FIG. 1 Drug Delivery Technologies: Market Segmentation
FIG. 2 Drug Delivery Technologies Market, 2014-2022 (USD Bn)
FIG. 3 Drug Delivery Technologies Market Share, by Mode of Administration, 2015 & 2022 (Value %)
FIG. 4 Drug Delivery Technologies Market Share, by Geography, 2015 (Value %)
FIG. 5 Fractal Map Analysis: by Key Market Players
FIG. 6 Attractive Investment Proposition, Drug Delivery Technologies Market, 2015
FIG. 7 Oral Drug Delivery Technology Market, 2014 - 2022 (USD Bn)
FIG. 8 Pulmonary Drug Delivery Technology Market, 2014 – 2022 (USD Bn)
FIG. 9 Transdermal Drug Delivery Technology Market, 2014-2022 (USD Bn)
FIG. 10 Injectable Drug Delivery Technology Market, 2014-2022 (USD Bn)
FIG. 11 Nasal Drug Delivery Technology Market, 2014-2022 (USD Bn)
FIG. 12 Implantable Drug Delivery Technology Market, 2014-2022 (USD Bn)
FIG. 13 Other Drug Delivery Technologies Market, 2014-2022 (USD Bn)
FIG. 14 U.S. Drug Delivery Technologies Market, 2014-2022 (USD Bn)
FIG. 15 Canada Drug Delivery Technologies Market, 2014-2022 (USD Bn)
FIG. 16 U.K. Drug Delivery Technologies Market, 2014-2022 (USD Bn)
FIG. 17 Germany Drug Delivery Technologies Market, 2014-2022 (USD Bn)
FIG. 18 Rest of Europe Drug Delivery Technologies Market, 2014-2022 (USD Mn Bn)
FIG. 19 Japan Drug Delivery Technologies Market, 2014-2022 (USD Bn)
FIG. 20 China Drug Delivery Technologies Market, 2014-2022 (USD Bn)
FIG. 21 Rest of Asia-Pacific Drug Delivery Technologies Market, 2014-2022 (USD Bn)
FIG. 22 Middle East and Africa Drug Delivery Technologies Market, 2014 – 2022 (USD Bn)
FIG. 23 Latin America Drug Delivery Technologies Market, 2014-2022 (USD Bn)

List of Tables

TABLE 1 Global Drug Delivery Technologies Market, by Mode of Administration, 2014–2022 (USD Bn)
TABLE 2 Global Drug Delivery Technologies Market, by Geography, 2014 – 2022 (USD Bn)
TABLE 3 North America Drug Delivery Technologies Market, by Country, 2014 – 2022 (USD Bn)
TABLE 4 Europe Drug Delivery Technologies Market, by Country, 2014 – 2022 (USD Bn)
TABLE 5 Asia-Pacific Drug Delivery Technologies Market, by Country, 2014 – 2022 (USD Bn)

Oral, injectable, implantable, pulmonary, transdermal, nasal, and ocular, buccal and others are the prime segments of drug delivery technologies market. Oral and injectable administrations are the oldest modes of drug delivery and together take over 55% market share in 2015. The two modes represent the widest range of drugs in the pharmaceuticals market and are observed to be the most affordable methods accepted worldwide.

Drug Delivery Technologies Market  

Major factors determining the growth of this market are the growing incidence of chronic diseases, rapid innovation, technological development and the ongoing growth of biologics market. Additionally, the demand for transdermal delivery methods is estimated to flourish during the forecast period. Convenience in use, ease of self administration, accuracy of delivering right dosage at right location, and painless drug delivery are the prime factors contributing the growth of transdermal drug delivery segment.

Implantable drug delivery segment will undergo the fastest growth during the forecast period. Specific site drug administration, reduction in burden of patient compliance and advantage of sustained drug release are the prime factors that drive the growth of this segment.

In terms of geographic distribution, North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America cumulatively make the global drug delivery technologies market.

Drug Delivery Technologies Market 

North America and Europe together capture over 60% of the global drug delivery technologies market revenue. Adoption of novel non-oral drug administration modes such as transdermal, implantable and pulmonary drug delivery is rapid and on a large scale in North America. Products such as dry powder inhalers, pen injectors for seasonal allergies, orodispersable tablets and other control release products are in high demand in the developed markets. Use of implantable devices such as drug eluting stents is increasingly used in treating chronic illnesses and for contraception.

Moreover, major players in the developing drug delivery technologies are primarily domiciled in Europe and U.S., thus giving the regions an early bird advantage in terms of rapid product adoption. High level of awareness among both care givers and patients also significantly contributes to the above trend. Intense competition among drug manufacturers and growing trend of outsourcing of manufacturing process has made this market fragmented, with numerous players coming up with newer drug delivery formulations technologies. This report also studies the global drug delivery technologies market based on major national and regional level. The classification is as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • Latin America
  • Middle East Africa
Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients